Gyre Therapeutics (GYRE) EBT Margin Growth (1y) (2011 - 2026)
Gyre Therapeutics (GYRE) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 452.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,076.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9,422.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,911.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,565.00 |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | -4,430.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,430.00 |
| Mar 31, 2026 | -6,203.00 |
| Dec 31, 2025 | -295.00 |
| Sep 30, 2025 | 954.00 |
| Jun 30, 2025 | -1,556.00 |
| Mar 31, 2025 | -2,492.00 |
| Dec 31, 2024 | 37,215.00 |
| Sep 30, 2024 | -1,950.00 |
| Jun 30, 2024 | 396.00 |
| Mar 31, 2024 | 2,078.00 |
| Dec 31, 2023 | -34,691.00 |
| Mar 31, 2023 | 185,588.00 |
| Dec 31, 2022 | 85,152.00 |
| Mar 31, 2022 | -28,881.00 |
| Dec 31, 2021 | 6,526.00 |
| Sep 30, 2021 | 61,333.00 |
| Jun 30, 2021 | -86,673.00 |
| Mar 31, 2021 | -150,786.00 |
| Mar 31, 2018 | -11.86 Mn |
| Dec 31, 2017 | 347,257.00 |